ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ...
Learning how a physical system behaves usually means repeating measurements and using statistics to uncover patterns. That ...
The quantum computing startup has outperformed the broader market in 2025, but its rise has left it trading at a hefty ...
From frozen bonfires to quantum physics, why light still matters to our hopes, our science and our long Alaska winters.
Reflecting on the Mufti Shamail Nadwi-Javed Akhtar exchange, this article calls for philosophical literacy, epistemic ...
At the heart of the friction is a simple contrast. The ledger must be immutable, reconcilable to the last decimal, and ...
Four ways of ending life remain or have become legal in the eyes of at least some of the United States, notes the aut ...
Bitcoin depends on encryption to remain secure. This encryption protects transactions, wallets, and user funds. If the ...
The Chosun Ilbo on MSNOpinion
AI-era competitiveness rooted in classical fundamentals
One thing not strictly required to join Palantir, one of the world’s leading artificial intelligence (AI) companies, is a ...
The time for building parallel centres of power and prosperity in India has begun, for American democracy is being tested by ...
Cantor Fitzgerald initiated coverage of ArriVent Biopharma (AVBP) with an Overweight rating. Firmonertinib is approved in China for first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results